NCT00392808View on ClinicalTrials.gov

Immunogenicity of the Booster Dose of Two MenC Vaccines

PHASE4CompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions
Meningococcal Infection
Interventions
BIOLOGICAL

conjugated polysaccharide menC vaccine

Booster vaccine dose at 14 to 18 months.

Trial Locations (2)

28922

Universidad Rey Juan Carlos I, Madrid

46020

Centro Superior Investigación en Salud Publica, Valencia

All Listed Sponsors
lead

Centro Superior de Investigación en Salud Publica

OTHER_GOV

NCT00392808 - Immunogenicity of the Booster Dose of Two MenC Vaccines | Biotech Hunter | Biotech Hunter